News from the life sciences and technology communities north of Boston
|
|
|
Congratulations to the team at Endolytix Technology, Inc. on the company's 5,600 SF expansion at 48 Dunham Ridge, Beverly. Endolytix is developing novel therapeutics to address the most resistant of antibiotic infections that are difficult to access and treat, and have low patient tolerance for current therapies. The new suite will be used for protein production and purification. Jason Holder, Ph.D. is the company founder and CSO.
|
|
Endolytix is part of an innovative life sciences and technology community at Dunham Ridge. Neighbors include:
|
|
We are pleased to welcome QSM Diagnostics to its new facility at 3 Gill Street, Woburn. The company's patented technology and mail-in tests allow veterinarians to diagnose and monitor bacterial infections in companion animals quickly and accurately. Edgar Goluch is QSM Diagnostics' founder and CEO.
|
|
|
|
|
Sanguine Biosciences has relocated its corporate headquarters from Waltham to 400 West Cummings Park, Woburn. The company is accelerating personalized medicine by facilitating biomedical research, enabling patients to participate from the comfort of their own home. Bo Cross is Sanguine's vice president of operations.
|
|
Kerry Love (left) and Rachel Chikwamba
|
|
Kerry Love, Ph.D., founder, CEO, and president of Sunflower Therapeutics (200 Boston Avenue, Medford) and Rachel Chikwamba, Ph.D., group executive, advanced chemistry and life sciences for Council for Scientific and Industrial Research in South Africa, recently made a case for greater pharmaceutical production capabilities in low- and-middle-income countries (LMIC) in a letter to Nature (subscription required).
|
|
The Medicine Maker spoke with the two life sciences leaders about how new technologies can support small-scale manufacturing capacity in LMIC.
|
|
"Small footprint manufacturing technologies can lower the barriers to entry for diverse future market participants. For example, technologies that are smaller, fully integrated, and automated are cheaper to install, require less resources to sustain, and can enable costs of goods that are competitive with enough facilities that rely on economies of scale.”
|
|
Founder, CEO, and president
Sunflower Therapeutics
|
|
GreenLight Biosciences, also at 200 Boston Avenue, is similarly focused on providing access to therapeutics to low- and middle-income countries.
GreenLight has received regulatory approval from the Rwanda Food and Drugs Authority (Rwanda FDA) to start a Phase I/II clinical trial of its vaccine candidate against COVID-19, as a booster to previously vaccinated individuals. Preparations for the trial are underway. Read more in Clinical Trials Arena.
|
|
|
|
“It is especially important to develop vaccines that are globally affordable and scalable. GreenLight’s efforts to initiate this clinical study in Rwanda show the company’s commitment to support Africa’s goal of affordable vaccine self-sufficiency.”
Co-founder, president, and CEO
GreenLight Biosciences
|
|
With the federal COVID-19 public health emergency slated to end on May 11, Moderna has been criticized for reported plans to increase COVID-19 vaccine prices. The company stated yesterday that its COVID-19 vaccines will continue to be available at no cost, regardless of an individual's insurance status, whether received at a doctor's office or local pharmacy. COVID vaccines will continue to be covered by Medicare Part B and most private insurance plans with no cost-sharing. For uninsured or underinsured people, Moderna’s patient assistance program will provide the vaccines at no cost. CEO Stéphane Bancel has agreed to appear before the Senate Committee on Health, Education, Labor and Pensions on March 22. Read more in Endpoints News.
|
|
Previously, Christine was senior director, portfolio and scientific operations for Breakthrough Properties. In her new role, she will build on the work of NSIV's founding COO and entrepreneurial leader, Tom Kinneman, who will remain actively involved in the organization as executive in residence.
"NSIV has a great track record with its companies. The continued demand for facilities and the infrastructure here in MetroNorth to support startups and scaling companies make this an excellent time to be part of the expansion and growth," said Kressirer. Read more.
|
|
C2i Accelerator (299 Washington Street, Woburn) welcomes new member AlpaLifeB Inc. The company offers the distribution of nanobody reagents to research labs in academia and industry, as well as nanobody discovery services.
|
|
The $200K Challenge is an annual startup competition hosted by M2D2, focused on identifying and rewarding disruptive companies in the medical technology and biotechnology industries. The 2023 Challenge deadline has been extended to 11:59 PM ET on Monday, February 20. If selected, startups and entrepreneurs will be in the running for more than $200,000 in in-kind resources and funding. Read more and apply.
|
|
100 Cummings Center, Beverly
1,503 SF Lab - Available Now
|
|
This move-in ready lab and office is now available at the bustling life sciences and business campus at Cummings Center.
Lab features include:
|
|
- Two 6’ fume hoods
- Ample bench space
- Chemical storage area
- Gas distribution piping
|
|
- Emergency eye wash and shower
- Additional exhaust drops
- Dedicated electrical outlets for equipment
- Sink with point-of-use acid neutralization tank
|
|
We'll be there...will you?
MassBio hosts its next Regional Mixer at Lord Hobo Brewing Co. in Woburn. This members-only event is an opportunity to connect with coworkers, network with other life sciences professionals in the area, or just kick back. Appetizers and drinks will be served. Thursday, February 16, 5:00 - 7:00 PM. Register.
|
|
Join North Shore Technology Council for an evening of beer tasting and networking at the brewery. The event brings together the NSTC biosciences, technology, and sustainability special interest groups. Tuesday, February 28, 5:00 - 7:00 PM, Granite Coast Brewing, Peabody. The entrance cost is $10 for members and $25 for non-members, and includes two drink tickets and food. Register.
|
|
|
|
We welcome your feedback on this newsletter and invite readers to share company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at svh@cummings.com to offer your news for upcoming newsletters. We look forward to hearing from you.
|
|
|
|
|
|
|
